Linked Life Data

17893234

Source:http://linkedlifedata.com/resource/pubmed/id/17893234

Statements in which the resource exists.
SubjectPredicateObjectContext
pubmed-article:17893234rdf:typepubmed:Citationlld:pubmed
pubmed-article:17893234lifeskim:mentionsumls-concept:C0086418lld:lifeskim
pubmed-article:17893234lifeskim:mentionsumls-concept:C0006826lld:lifeskim
pubmed-article:17893234lifeskim:mentionsumls-concept:C0000768lld:lifeskim
pubmed-article:17893234lifeskim:mentionsumls-concept:C0599849lld:lifeskim
pubmed-article:17893234lifeskim:mentionsumls-concept:C0332281lld:lifeskim
pubmed-article:17893234lifeskim:mentionsumls-concept:C0376452lld:lifeskim
pubmed-article:17893234lifeskim:mentionsumls-concept:C1705165lld:lifeskim
pubmed-article:17893234lifeskim:mentionsumls-concept:C1511681lld:lifeskim
pubmed-article:17893234lifeskim:mentionsumls-concept:C2700061lld:lifeskim
pubmed-article:17893234lifeskim:mentionsumls-concept:C1514391lld:lifeskim
pubmed-article:17893234lifeskim:mentionsumls-concept:C1515926lld:lifeskim
pubmed-article:17893234pubmed:issue12lld:pubmed
pubmed-article:17893234pubmed:dateCreated2007-12-6lld:pubmed
pubmed-article:17893234pubmed:abstractTextAlterations of DNA methylation are one of the most consistent epigenetic changes in human cancers. Human cancers generally show global DNA hypomethylation accompanied by region-specific hypermethylation. Alterations of DNA methylation may result in chromosomal instability as a result of changes in chromatin structure. DNA hypermethylation of CpG islands silences various tumor-related genes. Alterations of DNA methylation are frequently observed in cancers associated with chronic inflammation and/or persistent infection with viruses or other pathogenic microorganisms, such as hepatitis B or C viruses, Epstein-Barr virus, human papillomavirus and Helicobacter pylori, or with cigarette smoking. Accumulating evidence suggests that alterations of DNA methylation are involved even in the early and precancerous stages. On the other hand, in patients with cancers, aberrant DNA methylation is significantly associated with poorer tumor differentiation, tumor aggressiveness and poor prognosis. Precancerous conditions showing alterations of DNA methylation may progress rapidly and generate more malignant cancers. DNA methyltransferase (DNMT) 1 over-expression is not a secondary result of increased cell proliferative activity but is significantly correlated with the CpG island methylator phenotype, which is defined as frequent DNA hypermethylation of C-type CpG islands that are usually methylated in a cancer-specific (not age-dependent) manner. Splicing alteration of DNMT3b may result in chromosomal instability through DNA hypomethylation of pericentromeric satellite regions. Alteration of DNA methylation may become an indicator for carcinogenetic risk estimation and early diagnosis of cancers and a biological predictor of poor prognosis in patients with cancers. Correction of DNA methylation status may offer a new strategy for prevention and therapy of cancers.lld:pubmed
pubmed-article:17893234pubmed:languageenglld:pubmed
pubmed-article:17893234pubmed:journalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:17893234pubmed:citationSubsetIMlld:pubmed
pubmed-article:17893234pubmed:chemicalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:17893234pubmed:chemicalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:17893234pubmed:chemicalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:17893234pubmed:statusMEDLINElld:pubmed
pubmed-article:17893234pubmed:monthDeclld:pubmed
pubmed-article:17893234pubmed:issn1460-2180lld:pubmed
pubmed-article:17893234pubmed:authorpubmed-author:HirohashiSets...lld:pubmed
pubmed-article:17893234pubmed:authorpubmed-author:KanaiYaeYlld:pubmed
pubmed-article:17893234pubmed:issnTypeElectroniclld:pubmed
pubmed-article:17893234pubmed:volume28lld:pubmed
pubmed-article:17893234pubmed:ownerNLMlld:pubmed
pubmed-article:17893234pubmed:authorsCompleteYlld:pubmed
pubmed-article:17893234pubmed:pagination2434-42lld:pubmed
pubmed-article:17893234pubmed:dateRevised2010-5-21lld:pubmed
pubmed-article:17893234pubmed:meshHeadingpubmed-meshheading:17893234...lld:pubmed
pubmed-article:17893234pubmed:meshHeadingpubmed-meshheading:17893234...lld:pubmed
pubmed-article:17893234pubmed:meshHeadingpubmed-meshheading:17893234...lld:pubmed
pubmed-article:17893234pubmed:meshHeadingpubmed-meshheading:17893234...lld:pubmed
pubmed-article:17893234pubmed:meshHeadingpubmed-meshheading:17893234...lld:pubmed
pubmed-article:17893234pubmed:meshHeadingpubmed-meshheading:17893234...lld:pubmed
pubmed-article:17893234pubmed:meshHeadingpubmed-meshheading:17893234...lld:pubmed
pubmed-article:17893234pubmed:meshHeadingpubmed-meshheading:17893234...lld:pubmed
pubmed-article:17893234pubmed:meshHeadingpubmed-meshheading:17893234...lld:pubmed
pubmed-article:17893234pubmed:year2007lld:pubmed
pubmed-article:17893234pubmed:articleTitleAlterations of DNA methylation associated with abnormalities of DNA methyltransferases in human cancers during transition from a precancerous to a malignant state.lld:pubmed
pubmed-article:17893234pubmed:affiliationPathology Division, National Cancer Center Research Institute, 5-1-1 Tsukiji, Chuo-ku, Tokyo 104-0045, Japan. ykanai@ncc.go.jplld:pubmed
pubmed-article:17893234pubmed:publicationTypeJournal Articlelld:pubmed
pubmed-article:17893234pubmed:publicationTypeReviewlld:pubmed
pubmed-article:17893234pubmed:publicationTypeResearch Support, Non-U.S. Gov'tlld:pubmed
entrez-gene:1786entrezgene:pubmedpubmed-article:17893234lld:entrezgene
http://linkedlifedata.com/r...entrezgene:pubmedpubmed-article:17893234lld:entrezgene
http://linkedlifedata.com/r...pubmed:referesTopubmed-article:17893234lld:pubmed
http://linkedlifedata.com/r...pubmed:referesTopubmed-article:17893234lld:pubmed
http://linkedlifedata.com/r...pubmed:referesTopubmed-article:17893234lld:pubmed
http://linkedlifedata.com/r...pubmed:referesTopubmed-article:17893234lld:pubmed
http://linkedlifedata.com/r...pubmed:referesTopubmed-article:17893234lld:pubmed
http://linkedlifedata.com/r...pubmed:referesTopubmed-article:17893234lld:pubmed
http://linkedlifedata.com/r...pubmed:referesTopubmed-article:17893234lld:pubmed
http://linkedlifedata.com/r...pubmed:referesTopubmed-article:17893234lld:pubmed
http://linkedlifedata.com/r...pubmed:referesTopubmed-article:17893234lld:pubmed
http://linkedlifedata.com/r...pubmed:referesTopubmed-article:17893234lld:pubmed
http://linkedlifedata.com/r...pubmed:referesTopubmed-article:17893234lld:pubmed
http://linkedlifedata.com/r...pubmed:referesTopubmed-article:17893234lld:pubmed
http://linkedlifedata.com/r...pubmed:referesTopubmed-article:17893234lld:pubmed
http://linkedlifedata.com/r...pubmed:referesTopubmed-article:17893234lld:pubmed
http://linkedlifedata.com/r...pubmed:referesTopubmed-article:17893234lld:pubmed